Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2010 Oct;70(4):481-91.
doi: 10.1111/j.1365-2125.2010.03682.x.

Information about adverse drug reactions reported in children: a qualitative review of empirical studies

Affiliations
Review

Information about adverse drug reactions reported in children: a qualitative review of empirical studies

Lise Aagaard et al. Br J Clin Pharmacol. 2010 Oct.

Abstract

Aim: To review the literature on adverse drug reactions (ADRs) in children with respect to occurrence, seriousness, type, therapeutic group, age and gender of the child and category of reporter.

Methods: Medline and Embase databases were searched from origin and updated until February 2010. We included empirically based articles on ADRs in populations aged 0 to 17 years. Studies monitoring ADRs in patients with particular conditions or drug exposure were excluded. We extracted information about types and seriousness of ADRs, therapeutic groups, age and gender of the child and category of reporter. ADR occurrence was calculated as incidence rate and prevalence.

Results: We included 33 studies monitoring ADRs in general paediatric populations. The highest numbers of ADRs were reported in national ADR databases where data were collected over a longer period than in studies monitoring inpatients and outpatients. However, prevalence and incidence were much lower in the national databases. Types of reported ADRs, seriousness of ADRs and types of medicines differed substantially between studies due to differences in time periods and patient populations. Information about ADRs was mainly provided by health care professionals, although parents also contributed reports.

Conclusions: We found a higher incidence rate of ADRs in hospitalized children and outpatients than in national databases. There seems to be considerable potential for increasing the knowledge of ADRs by advocating the submission of reports to the spontaneous reporting systems. Our study underscores that ADRs in children constitute a significant public health problem.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Flow chart of included/excluded studies

References

    1. Miller MR, Zhan C. Pediatric patient safety in hospitals: a national picture in 2000. Pediatrics. 2004;113:1741–6. - PubMed
    1. Kongkaew C, Noyce PR, Ascroft DM. Hospital admissions associated with adverse drug reactions: a systematic review of prospective observational studies. Ann Pharmacother. 2008;42:1017–25. - PubMed
    1. Sammons HM, Choonara I. Clinical trials of medication in children, 1996–2002. Eur J Clin Pharmacol. 2005;61:165–7. - PubMed
    1. Conroy S, McIntyre J, Choonara I, Stephenson T. Drug trials in children: problems and the way forward. Br J Clin Pharmacol. 2000;49:93–7. - PMC - PubMed
    1. FDA Modernization Act of 1997. Available at http://www.fda.gov/RegulatoryInformation/Legislation/FederalFoodDrugandC... (last accessed 5 May 2010)